Deutsche Beteiligungs AG (DBAG) has announced that the NAV of its private equity investments increased to €437.3m in Q1 2021, marking a 3.6% growth compared with the beginning of its previous financial year.
Fund invests in renewable chemistry, regenerative medicine and agri-food across the Netherlands, Belgium and parts of Germany
Company will operate with the GP's existing test and measurement companies in the US and Denmark
Numerous Italian GPs with a generalist approach have reshaped their activity towards the tech sector
GP plans to merge Atlantic with portfolio company Maced, in which it acquired a majority stake last year